CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Brief Summary:The FREEDOM study aims to develop a scalable intervention to improve type 2 diabetes mellitus control in low-income Black adul...
Birmingham, Alabama, United States
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...
Birmingham, Alabama, United States and 44 other locations
the efficacy and safety of icovamenib in participants with Type 2 Diabetes who are not achieving glycemic targets despite antihyperglycemic ...
Phase 2
Birmingham, Alabama, United States and 14 other locations
placebo-controlled, multicenter to evaluate the efficacy, safety, and tolerability of AZD6234 in adults with overweight or obesity and type 2 diabetes...
Phase 2
Birmingham, Alabama, United States and 17 other locations
This is a phase 2 randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes...
Phase 2
Birmingham, Alabama, United States and 13 other locations
This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good...
Phase 2
Birmingham, Alabama, United States and 45 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Birmingham, Alabama, United States and 89 other locations
The primary objective of this study is to demonstrate that KAI-9531 subcutaneous (SC) injection once weekly is superior to placebo on:* Percent chang...
Phase 3
Cullman, Alabama, United States and 36 other locations
implementation study to improve guideline-recommended screening and treatment of chronic kidney disease (CKD) in individuals with type 2 diabetes...
Birmingham, Alabama, United States and 5 other locations
IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes...
Birmingham, Alabama, United States and 5 other locations
Clinical trials
Research sites
Resources
Legal